Getting to grips with the implications of the rapid advances in the life sciences.
Potential hostile misuses of neurotechnologies and neurological drugs should be examined as new dual-use issues emerge.
Civil society and BWC member states must begin discussions now, rather than later, if they want to present viable options and strategies that will influence next year's conference.
Discoveries that drugs and bioregulators can quickly be routed to the brain through the nose illustrates the scope of dual-use threats and the need to prevent future misuse.
As advances in the life sciences continue at a breakneck pace, bioethicists will be needed to guide researchers through serious dual-use dilemmas.
The inconsistent U.S. message on verification of the Biological Weapons Convention compared with other international treaties leaves some with nightmares.
After years of discussion around teaching a "culture of responsibility" to life scientists, it's about time to put talk into practice.
Despite some criticism, opponents of biological and chemical weapons recognize the opportunity for increased weapons control that lies in the next two meetings of ICC Member States.
Few policy makers can say they are familiar with the intricate connections between biology and security. But two recent publications point the way toward refocusing policy on this important relationship.
Civil society can play an important role in the discourse that will define the Biological Weapons Convention into the future. But action must start now if there is to be meaningful change.
It's time to give credit where credit's due. A Westminster report shows British MPs are looking closely at their government's biosecurity policies.
Although the BWC lacks an enforcement mechanism, for the moment it's the most efficient way of reconciling the best and worst of biotechnology.
A new report by a prominent U.S. biosecurity group presents a strategy for getting the word out on dual-use life science research. Will the world follow?
Two recent papers suggest that U.S. security and U.S. biomedical science could benefit from the complex assessment that the systems analysis approach provides.
Two recent bioethical studies assess current efforts to prevent the misuse of the life sciences and suggest alternatives.
Despite a number of dire assessments, advances in biotechnology don't have to lead to a bioweapons arms race.
Expanded biodefense research that lacks transparency compounds the risk that states will engage in biological arms races.
The arms control community needs to shed its bitterness about past efforts to reform the bioweapons regime and begin developing a new agenda for action.